RecruitingNCT07418385

Voluntary HIV Screening in the General Population in France

Sponsor

Université de Reims Champagne-Ardenne

Enrollment

1,000 participants

Start Date

Oct 7, 2025

Study Type

OBSERVATIONAL

Conditions

Human Immunodeficiency Virus (HIV)

Summary

Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed. Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

years of age or older
Male or female
Regardless of sexual orientation
Whether or not they have previously undergone voluntary HIV testing
Agreeing to participate in the study.

Exclusion Criteria2

Minors
Refusing to participate in the study

Interventions

OTHERdata collections

data collections

Locations(1)

Ufr Medecine Urca

Reims, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07418385

Related Trials

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT0707162327 locations

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT0704429770 locations